Alain Fourquet
#163,816
Most Influential Person Now
Alain Fourquet's AcademicInfluence.com Rankings
Alain Fourquetmedical Degrees
Medical
#3343
World Rank
#3811
Historical Rank
Oncology
#234
World Rank
#242
Historical Rank

Alain Fourquetphilosophy Degrees
Philosophy
#9552
World Rank
#13129
Historical Rank
Logic
#6525
World Rank
#8049
Historical Rank

Download Badge
Medical Philosophy
Alain Fourquet's Degrees
- Doctorate Medicine Université Paris Cité
- PhD Oncology Université Paris Cité
Why Is Alain Fourquet Influential?
(Suggest an Edit or Addition)Alain Fourquet's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. (2001) (935)
- Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer. (2015) (812)
- Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial (2007) (705)
- Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. (1989) (498)
- Age as prognostic factor in premenopausal breast carcinoma (1993) (480)
- Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial. (2015) (467)
- Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6. (1994) (438)
- Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. (2007) (415)
- Infiltrating lobular carcinoma of the breast: Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns (1996) (414)
- Male breast cancer (1998) (377)
- Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. (1996) (368)
- The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. (2000) (323)
- Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer (1992) (310)
- Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review (2011) (294)
- The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer. (2012) (265)
- Radiation‐induced sarcomas after radiotherapy for breast carcinoma (2005) (231)
- Is obesity an independent prognosis factor in woman breast cancer? (2008) (229)
- Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast‐conserving surgery and definitive irradiation correlation of pathologic parameters with outcome of treatment (1993) (212)
- Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'. (2008) (210)
- Long‐term outcome after breast‐conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast (2005) (196)
- Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? (2003) (192)
- Familial invasive breast cancers: worse outcome related to BRCA1 mutations. (2000) (186)
- Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity (2007) (182)
- No significant predictive value of c‐ erbB‐2 or p53 expression regarding sensitivity to primary chemotherapy or radiotherapy in breast cancer (1998) (181)
- Contralateral breast cancer: annual incidence and risk parameters. (1995) (177)
- Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. (2004) (174)
- Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging. (1993) (172)
- Local control and survival of breast cancer treated by limited surgery followed by irradiation. (1986) (169)
- Integrated Genomic and Transcriptomic Analysis of Ductal Carcinoma In situ of the Breast (2008) (165)
- Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882. (2007) (165)
- Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial. (2009) (164)
- The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer. (1999) (164)
- BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group. (1997) (163)
- Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity. (1994) (160)
- Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status. (2001) (159)
- Comparison of the prognostic value of Scarff-Bloom-Richardson and Nottingham histological grades in a series of 825 cases of breast cancer: major importance of the mitotic count as a component of both grading systems. (1998) (158)
- Ten‐year results of breast‐conserving surgery and definitive irradiation for intraductal carcinoma (ductal carcinoma in situ) of the breast (1991) (155)
- KIT is highly expressed in adenoid cystic carcinoma of the breast, a basal-like carcinoma associated with a favorable outcome (2005) (150)
- The influence of the boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trial. (2004) (143)
- Primary chemotherapy for operable breast cancer: incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conserving surgery. (2001) (140)
- Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first. (2007) (139)
- Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy. (2005) (133)
- Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial. (2009) (130)
- Risk of second malignancies after adjuvant radiotherapy for breast cancer: a large-scale, single-institution review. (2007) (129)
- Ophthalmologic and intraocular non‐Hodgkin's lymphoma: a large single centre study of initial characteristics, natural history, and prognostic factors (2004) (127)
- Second malignancies after breast cancer: the impact of different treatment modalities (2008) (119)
- Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925) (2010) (113)
- Short and long‐term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trial (1999) (112)
- Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial (2017) (109)
- Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature (2010) (104)
- ONCOPOOL - a European database for 16,944 cases of breast cancer. (2010) (103)
- The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trial. (2008) (101)
- Conservative management of intraductal breast carcinoma with tumorectomy and radiation therapy (1986) (100)
- Breast radiotherapy in the lateral decubitus position: A technique to prevent lung and heart irradiation. (2005) (100)
- Conservative treatment of lower pole breast cancers by bilateral mammoplasty and radiotherapy. (1998) (96)
- Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial. (2020) (95)
- Breast-conserving treatment in the elderly: long-term results of adjuvant hypofractionated and normofractionated radiotherapy. (2009) (94)
- p53 mutation as a genetic trait of typical medullary breast carcinoma. (1999) (94)
- Primary breast non‐Hodgkin's lymphoma: A large single center study of initial characteristics, natural history, and prognostic factors (2009) (91)
- Survival in early-onset BRCA1 breast-cancer patients (1998) (90)
- Postmastectomy radiotherapy: questions for the twenty-first century. (1998) (89)
- Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized study. (2005) (88)
- Circulating macrophage colony stimulating factor as a marker of tumour progression. (2002) (84)
- Characteristics and outcome of 1755 operable breast cancers in women over 70 years of age. (2004) (83)
- Visualizing chromosomes as transcriptome correlation maps: evidence of chromosomal domains containing co-expressed genes--a study of 130 invasive ductal breast carcinomas. (2005) (80)
- Topical superoxide dismutase reduces post‐irradiation breast cancer fibrosis (2004) (80)
- Cardiac toxicity in breast cancer patients: from a fractional point of view to a global assessment. (2011) (78)
- Conservative treatment of early breast cancer: prognostic value of the ductal in situ component and other pathological variables on local control and survival. Long-term results. (1989) (76)
- LMCE3 treatment strategy: results in 99 consecutively diagnosed stage 4 neuroblastomas in children older than 1 year at diagnosis. (2000) (76)
- Simultaneous bilateral breast carcinomas: a retrospective review of 149 cases. (1994) (75)
- CT-scan based localization of the internal mammary chain and supra clavicular nodes for breast cancer radiation therapy planning. (2006) (74)
- Single dose versus fractionated total body irradiation before bone marrow transplantation: radiobiological and clinical considerations. (1994) (73)
- Postmastectomy electron beam chest wall irradiation in women with breast cancer: a clinical step toward conformal electron therapy. (2007) (72)
- Phytoestrogens after breast cancer. (2001) (70)
- A prognostic DNA signature for T1T2 node‐negative breast cancer patients (2010) (70)
- In vitro radiation-induced apoptosis and early response to low-dose radiotherapy in non-Hodgkin's lymphomas. (1998) (69)
- Simultaneous integrated boost in breast conserving treatment of breast cancer: a dosimetric comparison of helical tomotherapy and three-dimensional conformal radiotherapy. (2010) (68)
- Salvage treatment for local recurrence following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast. (1994) (67)
- Can we decrease the skin reaction in breast cancer patients using hyaluronic acid during radiation therapy? Results of phase III randomised trial. (2011) (67)
- Search for a Gene Expression Signature of Breast Cancer Local Recurrence in Young Women (2012) (65)
- Improving the definition of tumor bed boost with the use of surgical clips and image registration in breast cancer patients. (2010) (64)
- Association of Radiotherapy Boost for Ductal Carcinoma In Situ With Local Control After Whole-Breast Radiotherapy (2017) (64)
- Preliminary results of whole brain radiotherapy with concurrent trastuzumab for treatment of brain metastases in breast cancer patients. (2011) (64)
- How to boost the breast tumor bed? A multidisciplinary approach in eight steps. (2008) (62)
- Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trial. (2007) (62)
- Pathological response to preoperative concurrent chemo-radiotherapy for breast cancer: results of a phase II study. (2006) (62)
- Iridium-192 versus cobalt-60 boost in 3-7 cm breast cancer treated by irradiation alone: final results of a randomized trial. (1995) (62)
- Salvage treatment for local recurrence after breast‐conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast (2001) (61)
- Breast cancer in elderly women: a retrospective analysis of combined treatment with tamoxifen and once-weekly irradiation. (1995) (60)
- High-resolution mapping of DNA breakpoints to define true recurrences among ipsilateral breast cancers. (2008) (60)
- Lobular invasive carcinoma of the breast is a molecular entity distinct from luminal invasive ductal carcinoma. (2010) (59)
- Anatomical, clinical and radiological delineation of target volumes in breast cancer radiotherapy planning: individual variability, questions and answers. (2009) (59)
- Radiotherapy for invasive breast cancer: guidelines for clinical practice from the French expert review board of Nice/Saint-Paul de Vence. (2011) (58)
- Paget's disease of the nipple without detectable breast tumor: conservative management with radiation therapy. (1987) (58)
- Breast irradiation in the lateral decubitus position: technique of the Institut Curie. (1991) (56)
- Low expression of bcl-2 in Brca1-associated breast cancers (2000) (56)
- ERBB2 overexpression in breast carcinomas: no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapy. (2000) (55)
- Biological and clinical significance of concurrent p53 gene alterations, MDR1 gene expression, and S-phase fraction analyses in breast cancer patients treated with primary chemotherapy or radiotherapy. (1997) (54)
- Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience (2009) (54)
- Presentation of axillary lymphadenopathy without detectable breast primary (T0 N1b breast cancer): experience at Institut Curie. (1989) (53)
- Helical tomotherapy and volumetric modulated arc therapy: New therapeutic arms in the breast cancer radiotherapy. (2016) (51)
- Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation. (1996) (50)
- Placing the boost in breast-conservation radiotherapy: A review of the role, indications and techniques for breast-boost radiotherapy. (2006) (50)
- Histological margin assessment for breast ductal carcinoma in situ: precision and implications (2004) (48)
- Simplified rules for everyday delineation of lymph node areas for breast cancer radiotherapy. (2010) (45)
- Whole breast radiotherapy in the lateral decubitus position: a dosimetric and clinical solution to decrease the doses to the organs at risk (OAR). (2014) (45)
- Familial Breast Cancer: Clinical Response to Induction Chemotherapy or Radiotherapy Related to BRCA1/2 Mutations Status (2009) (44)
- Preoperative breast radiation therapy: Indications and perspectives. (2017) (43)
- [Standards, Options and Recommendations for the management of ductal carcinoma in situ of the breast (DCIS): update 2004]. (2005) (43)
- Disseminated tumor cells and the risk of locoregional recurrence in nonmetastatic breast cancer. (2009) (43)
- In vivo induction of apoptosis in human lymphocytes by therapeutic fractionated total body irradiation. (1995) (41)
- Predictors for poor cosmetic outcome in patients with early stage breast cancer treated with breast conserving therapy: Results of the Young boost trial. (2018) (40)
- The acute skin and heart toxicity of a concurrent association of trastuzumab and locoregional breast radiotherapy including internal mammary chain: a single-institution study. (2011) (40)
- Concurrent administration of trastuzumab with locoregional breast radiotherapy: long-term results of a prospective study (2014) (38)
- Impact of a boost dose of 16 GY on the local control and cosmesis in patients with early breast cancer: The EORTC ‘boost versus no boost’ trial (2000) (38)
- EPID based in vivo dosimetry system: clinical experience and results (2016) (37)
- Analyzing prognostic factors in breast cancer using a multistate model (1999) (35)
- Preoperative radio-chemotherapy in early breast cancer patients: long-term results of a phase II trial. (2012) (35)
- Metachronous contralateral breast cancer as first event of relapse. (1996) (35)
- Urokinase-type plasminogen activator and plasminogen-activator-inhibitor type 1 predict metastases in good prognosis breast cancer patients. (2009) (34)
- Simplified field-in-field technique for a large-scale implementation in breast radiation treatment. (2012) (34)
- Whole-brain radiation therapy in breast cancer patients with brain metastases (2010) (34)
- Technique alternatives for breast radiation oncology: Conventional radiation therapy to tomotherapy (2009) (34)
- Visualisation of the left anterior descending coronary artery on CT images used for breast radiotherapy planning. (2013) (32)
- Risks of second malignancies after breast cancer treatment: Long-term results. (2017) (32)
- Quality assurance in breast cancer: EORTC experiences in the phase III trial on irradiation of the internal mammary nodes. (2007) (31)
- Prognostic Value of the S‐Phase Fraction of Breast Cancers Treated by Primary Radiotherapy or Neoadjuvant Chemotherapy (1993) (31)
- Potential benefits of using cardiac gated images to reduce the dose to the left anterior descending coronary during radiotherapy of left breast and internal mammary nodes. (2012) (31)
- Salvage treatment for local or local-regional recurrence after initial breast conservation treatment with radiation for ductal carcinoma in situ. (2005) (30)
- Plastic surgery for breast conservation therapy: how to define the volume of the tumor bed for the boost? (2014) (29)
- Long-Term Prognostic Performance of Ki67 Rate in Early Stage, pT1-pT2, pN0, Invasive Breast Carcinoma (2013) (29)
- Long term outcome of small size invasive breast carcinomas independent from angiogenesis in a series of 685 cases (2001) (29)
- Use of deformable image fusion to allow better definition of tumor bed boost volume after oncoplastic breast surgery. (2011) (28)
- Is radiotherapy an option for early breast cancers with complete clinical response after neoadjuvant chemotherapy? (2011) (28)
- Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage. (2009) (27)
- Conservative management of intraductal breast carcinoma with tumorectomy and radiation therapy. (1984) (27)
- Role of dynamic magnetic resonance imaging in the evaluation of tumor response to preoperative concurrent radiochemotherapy for large breast cancers: a prospective phase II study. (2007) (26)
- Comparison of passive-beam proton therapy, helical tomotherapy and 3D conformal radiation therapy in Hodgkin's lymphoma female patients receiving involved-field or involved site radiation therapy. (2016) (25)
- Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast-conserving surgery? Results of the ARCOSEIN multicenter, Phase III study: patients' and doctors' views. (2007) (25)
- Summary version of the standards, options and recommendations for nonmetastatic breast cancer (updated January 2001) (2003) (25)
- Concurrent capecitabine and whole-brain radiotherapy for treatment of brain metastases in breast cancer patients (2009) (25)
- Patient population analysis in EORTC trial 22881/10882 on the role of a booster dose in breast-conserving therapy. (1994) (25)
- Longitudinal clinical and functional pulmonary follow-up after megatherapy, fractionated total body irradiation, and autologous bone marrow transplantation for metastatic neuroblastoma. (1999) (24)
- Conjunctival low-grade non-Hodgkin's lymphoma: a large single-center study of initial characteristics, natural history and prognostic factors (2006) (24)
- Implant breast reconstruction followed by radiotherapy: can helical tomotherapy become a standard irradiation treatment? (2012) (24)
- Breat-conserving treatment of ductal carcinoma in situ (1992) (24)
- Paget's disease of the nipple without clinically and radiologically detectable breast tumor. Histochemical and immunohistochemical study of 44 cases. (1993) (24)
- The influence of the boost technique on local control in breast conserving treatment in the EORTC ‘boost versus no boost’ trial (2004) (23)
- Management of inflammatory breast cancer after neoadjuvant chemotherapy. (2011) (23)
- [Superoxide dismutase (Cu/Zn) in cutaneous application in the treatment of radiation-induced fibrosis]. (1994) (23)
- Medullary breast carcinoma: the role of radiotherapy as primary treatment. (1987) (23)
- Effects of superoxide dismutase topical treatment on human skin radiofibrosis: a pathological study (1996) (23)
- Combination of Olaparib and radiotherapy for triple negative breast cancer: preliminary results of the RADIOPARP phase I trial. (2020) (22)
- Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option. (2010) (22)
- S-phase fractions of breast cancer predict overall and post-relapse survival. (1997) (22)
- Whole breast radiotherapy in the lateral isocentric lateral decubitus position: Long-term efficacy and toxicity results. (2017) (22)
- A parametric regression model of tumor recurrence: An application to the analysis of clinical data on breast cancer (1996) (22)
- Management of advanced non‐melanoma skin cancers using helical tomotherapy (2014) (21)
- The use of helical tomotherapy in the treatment of early stage breast cancer: indications, tolerance, efficacy—a single center experience (2018) (21)
- Helical Tomotherapy for Inoperable Breast Cancer: A New Promising Tool (2013) (21)
- Genomic Instability: A Stronger Prognostic Marker Than Proliferation for Early Stage Luminal Breast Carcinomas (2013) (21)
- EPID based in vivo dosimetry system: clinical experience and results. (2016) (20)
- Concurrent use of palbociclib and radiation therapy: single-centre experience and review of the literature (2020) (20)
- Randomized Study Comparing Adjuvant Radiotherapy (RT) with Concomitant Chemotherapy (CT) Versus Sequential Treatment after Conservative Surgery for Patients with Stages I and II Breast Carcinoma: Long-term Results (2002) (20)
- Long-Term Results of a Highly Performing Conformal Electron Therapy Technique for Chest Wall Irradiation After Mastectomy. (2017) (20)
- High rates of breast conservation for large ductal and lobular invasive carcinomas combining multimodality strategies (2008) (20)
- [Management of malignant phyllodes tumors of the breast: the experience of the Institut Curie]. (2009) (20)
- The impact of the loco-regional treatment in elderly breast cancer patients: hypo-fractionated exclusive radiotherapy, single institution long-term results. (2010) (19)
- Evolution of radiation techniques in the treatment of breast cancer (BC) patients: From 3D conformal radiotherapy (3D CRT) to intensity-modulated RT (IMRT) using Helical Tomotherapy (HT). (2017) (19)
- Should We Move Beyond Mean Heart Dose? (2020) (19)
- Combination of radiotherapy and double blockade HER2 with pertuzumab and trastuzumab for HER2-positive metastatic or locally recurrent unresectable and/or metastatic breast cancer: Assessment of early toxicity. (2017) (19)
- Place of modern imaging modalities for solitary plasmacytoma: toward improved primary staging and treatment monitoring. (2012) (18)
- Factors associated with patient-reported cosmetic outcome in the Young Boost Breast Trial. (2016) (18)
- Lack of HIN-1 Methylation Defines Specific Breast Tumor Subtypes Including Medullary Carcinoma of the Breast and BRCA1-Linked Tumors (2003) (17)
- Responses to concurrent radiotherapy and hormone-therapy and outcome for large breast cancers in post-menopausal women. (2007) (17)
- Tumor aromatase expression as a prognostic factor for local control in young breast cancer patients after breast-conserving treatment (2009) (17)
- Side-ffects 15 Years after Lymph Node Irradiation in Breast Cancer: Randomized EORTC Trial 22922/10925. (2021) (17)
- Effects of low dose total body irradiation (LDTBI) and recombinant human interleukin-2 in mice. (1993) (16)
- 1076 Influence of surgery-radiotherapy interval on recurrence in breast-conserving treatment of small breast cancer (1995) (16)
- A radiotherapy contouring atlas for cardiac conduction node delineation. (2021) (16)
- Comparative image and flow cytometric TUNEL analysis of fine needle samples of breast carcinoma. (2001) (16)
- Breast radiotherapy in women with pectus excavatum (funnel chest): is the lateral decubitus technique an answer? A dosimetric study. (2006) (16)
- [Primary epidermoid carcinoma of the breast. Clinical, histopathologic and prognostic study of 14 patients]. (1992) (16)
- MANAGEMENT OF BREAST CANCER IN THE ELDERLY (1988) (16)
- High Ki67 expression is a risk marker of invasive relapse for classical lobular carcinoma in situ patients. (2012) (15)
- Prognostic significance of clinical nodal involvement in patients treated by radical radiotherapy for a locally advanced breast cancer (1984) (15)
- Solitary plasmocytoma: improvement in critical organs sparing by means of helical tomotherapy (2009) (15)
- The Limits of the Linear Quadratic (LQ) Model for Late Cardiotoxicity Prediction: Example of Hypofractionated Rotational Intensity Modulated Radiation Therapy (IMRT) for Breast Cancer. (2020) (15)
- Medullary breast carcinoma: prognostic implications of p53 expression. (2003) (15)
- Prognostic Impact of Time to Ipsilateral Breast Tumor Recurrence after Breast Conserving Surgery (2016) (14)
- OC-0523: Lymph node RT improves survival in breast cancer: 10 years results of the EORTC ROG and BCG phase III trial 22922/10925. (2014) (14)
- In vitro radiation-induced apoptosis and tumour response to radiotherapy: a prospective study in patients with non-Hodgkin lymphomas treated by low-dose irradiation. (1997) (14)
- Hydrosorb® versus control (water based spray) in the management of radio-induced skin toxicity: Results of multicentre controlled randomized trial. (2015) (14)
- Combination of Olaparib with radiotherapy for triple‐negative breast cancers: One‐year toxicity report of the RADIOPARP Phase I trial (2021) (14)
- Fifteen-year results of the randomised EORTC trial 22922/10925 investigating internal mammary and medial supraclavicular (IM-MS) lymph node irradiation in stage I-III breast cancer. (2018) (14)
- The Impact of Boost Dose and Margins on the Local Recurrence Rate in Breast Conserving Therapy: Results From the EORTC Boost-No Boost Trial (2007) (13)
- [Preliminary results of whole breast helical tomotherapy with simultaneous integrated boost in the adjuvant treatment of breast cancer]. (2014) (13)
- [Radiotherapy of invasive breast cancer: French national guidelines]. (2012) (13)
- [Tamoxifen and aromatase inhibitors in the treatment of breast cancer in menopausal women: pharmacological and clinical aspects]. (2004) (13)
- [Protontherapy: basis, indications and new technologies]. (2010) (13)
- [Controversy about internal mammary chain irradiation in breast cancer]. (2014) (13)
- Outcomes of postoperative radiation therapy for breast cancer in older women according to age and comorbidity status: An observational retrospective study in 752 patients. (2018) (12)
- Adjuvant Trastuzumab Emtansine (T-DM1) and Concurrent Radiotherapy for Residual Invasive HER2-positive Breast Cancer (2020) (12)
- Disseminated Tumor Cells Predict Efficacy of Regional Nodal Irradiation in Early Stage Breast Cancer. (2019) (12)
- Corrigendum to “Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first” [Radiother Oncol 82 (2007) 272–280] (2007) (12)
- [Radiotherapy of breast cancer]. (2002) (11)
- Optimization and auto-segmentation of a high risk cardiac zone for heart sparing in breast cancer radiotherapy. (2020) (11)
- Photons Without Bolus Versus Electrons With Bolus After Upfront Mastectomy Without Immediate Reconstruction in Breast Cancer Patients. (2019) (10)
- Validation over time of a nomogram including HER2 status to predict the sentinel node positivity in early breast carcinoma. (2012) (10)
- [Radiotherapy for breast cancer and pacemaker]. (2011) (10)
- Epigenomic Alterations in Breast Carcinoma from Primary Tumor to Locoregional Recurrences (2014) (10)
- [Thyroid cancer. A multidimensional analysis of prognostic factors]. (1983) (10)
- [Radiotherapy for breast cancer: respiratory and set-up uncertainties]. (2005) (10)
- [French national evaluation for helicoidal tomotherapy: description of indications, dose constraints and set-up margins]. (2007) (10)
- The fibroblast growth factor receptor 1 (FGFR1), a marker of response to chemoradiotherapy in breast cancer? (2012) (10)
- Clinical practice of breast cancer protontherapy: A single-centre experience from selection to treatment. (2021) (9)
- Twelve years of experience of breast cancer at the Institut Curie: improvement of survival and value of screening mammographics (1997) (9)
- Patterns of loco regional failure in women with breast cancer treated by Postmastectomy Conformal Electron Beam Radiation Therapy (PMERT): Large scale single center experience (2017) (9)
- [Phytoestrogens in the contraindication of hormone replacement therapy. The problem of breast cancer]. (2000) (8)
- Can we Reduce the Toxicity of the Mediastinal Irradiation Using New Highly Conformal Techniques (2014) (8)
- [Breast radiation therapy during COVID-19 outbreak: Practical advice]. (2020) (8)
- Cardiac substructure exposure in breast radiotherapy: a comparison between intensity modulated proton therapy and volumetric modulated arc therapy (2021) (8)
- Cancer controlatéral du sein : métastase ou second cancer primitif ? (1996) (8)
- Progressive inflammatory breast cancer in patient receiving chemotherapy: the importance of radiotherapy as a part of locoregional treatment. (2009) (8)
- [PARP inhibitors and radiotherapy: rational and prospects for a clinical use]. (2014) (8)
- Late toxicities and outcomes of adjuvant radiotherapy combined with concurrent bevacizumab in patients with triple-negative non-metastatic breast cancer. (2015) (8)
- Testing the Independence of Competing Risks: An Application to the Analysis of Breast Cancer Recurrence (1994) (8)
- 6N Irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer: state of the day of EORTC phase III trial 22922/10925 with 4004 patients (2010) (8)
- Breast cancer in premenopausal women : Is young age at diagnosis an independant prognostic factor? (1992) (8)
- [Breast-conserving therapy of breast cancer]. (2004) (8)
- Radiotherapy associated with concurrent bevacizumab in patients with non-metastatic breast cancer. (2014) (7)
- [Monocentric evaluation of the skin and cardiac toxicities of the concomitant administration of trastuzumab and radiotherapy]. (2009) (7)
- Preoperative radiation therapy: The 'new' targeted breast cancer treatment? (2017) (7)
- Concurrent capecitabine and whole-brain radiotherapy for treatment of brain metastases in breast cancer patients (2009) (7)
- Hypofractionated whole breast irradiation after conservative surgery for patients aged less than 60 years: a multi-centre comparative study (2019) (7)
- Pertuzumab and Trastuzumab Combination with Concomitant Locoregional Radiotherapy for the Treatment of Breast Cancers with HER2 Receptor Overexpression (2021) (7)
- Intraductal carcinoma of the breast: Long-term results with breast-conserving surgery and definitive irradiation (1993) (7)
- The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology. (2018) (7)
- Feasibility of helical tomotherapy for debulking irradiation before stem cell transplantation in malignant lymphoma. (2011) (7)
- [Paget's disease of the nipple without any associated mammary tumor clinically or radiologically detectable. Apropos of 51 cases treated at the Curie Institute]. (1987) (7)
- Use of helical tomotherapy in locally advanced and/or metastatic breast cancer for locoregional treatment. (2018) (6)
- A case-control study to identify molecular risk factors for local recurrence in young breast cancer patients. (2020) (6)
- [Ductal carcinoma in situ of the breast (DCIS). Histopathological features and treatment modalities: analysis of 1,289 cases]. (2010) (6)
- The place of the boost in the breast cancer treatment: State of art. (2022) (6)
- Preliminary experience of whole-brain radiation therapy (WBRT) in breast cancer patients with brain metastases previously treated with bevacizumab-based chemotherapy (2011) (6)
- [Contralateral breast cancer: metastasis or second primary cancer?]. (1996) (6)
- The association of internal mammary and medial supraclavicular lymph node radiation technique with clinical outcomes: results from the EORTC 22922/10925 randomised trial. (2022) (6)
- Assessment of a conventional volumetric-modulated arc therapy knowledge-based planning model applied to the new Halcyon© O-ring linac in locoregional breast cancer radiotherapy. (2021) (6)
- [Radiation-induced sarcomas after breast cancer: experience of Institute Curie and review of literature]. (2006) (6)
- The role of helical tomotherapy in the treatment of bone plasmacytoma. (2012) (6)
- Prospective and Comparative Evaluation of the Toxicity of Adjuvant Concurrent Chemoradiotherapy After Neoadjuvant Chemotherapy for Breast Cancer (2013) (5)
- [Stoutness and prognosis of female non-metastatic breast cancer: results from a French observational cohort study]. (2009) (5)
- Are ipsilateral breast tumour invasive recurrences in young (⩽40 years) women more aggressive than their primary tumours? (2007) (5)
- Severe acute radiation-related skin toxicity in a breast cancer patient with Behçet's disease. (2009) (5)
- [Concurrent radiation therapy and dual HER2 blockade in breast cancer: Assessment of toxicity]. (2021) (5)
- Dosimetric comparison of four high performance techniques for irradiation of breast cancer patients. (2021) (5)
- Radiation dose homogeneity in an EORTC multicenter trial on breast irradiation. (1999) (5)
- Sequence of radiotherapy and chemotherapy after breast-conserving surgery in small invasive breast cancer (2000) (5)
- Out-of-hospital follow-up after low risk breast cancer within a care network: 14-year results. (2014) (5)
- Helical tomotherapy and systemic targeted therapies in solitary plasmacytoma: Pilot study. (2013) (5)
- [Definition of nodal volumes in breast cancer treatment and segmentation guidelines]. (2009) (5)
- [Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conservative surgery enhances late toxicities]. (2006) (5)
- Risk of second non breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving treatment (2006) (4)
- P4-17-02: Whole-Brain Radiation Therapy Plus Concomitant Temozolomide for the Treatment of Brain Metastases from Breast Cancer: A Randomized Prospective Multicenter Phase II Study. (2011) (4)
- Development of simplified auto-segmentable functional cardiac atlas. (2022) (4)
- Multicentre combined chemotherapy protocol for large cell advanced non hodgkin's lymphoma (2006) (4)
- Left Breast Cancer Treated in Isocentric Lateral Decubitus (ILD) Position: An Alternative Technique Sparing Organs at Risk (OAR) (2013) (4)
- Radioparp: A phase I of olaparib with radiation therapy (RT) in patients with inflammatory, locoregionally advanced or metastatic triple-negative breast cancer (TNBC) or patient with operated TNBC with residual disease—Preliminary results. (2020) (4)
- [Meta-analyses of the effects of radiotherapy in breast cancer: the ultimate evidence?]. (2008) (4)
- Prognostic factors for local recurrence following breast-conserving treatment in young women (2010) (4)
- The impact of isolated local recurrence on long-term outcome in early-breast cancer patients after breast-conserving therapy. (2021) (4)
- Impact of the boost dose on local control and survival in patients with early stage breast cancer after a microscopically incomplete lumpectomy : 10 years results of the randomised EORTC boost trial 22881/10882. (2006) (4)
- 6LBA The benefit of regional irradiation in stage I–III breast cancer: 10 years results of the EORTC ROG and BCG phase III trial 22922/10925 (2014) (4)
- Concurrent use of aromatase inhibitors and hypofractionated radiation therapy. (2012) (4)
- Significance of margins of excision on breast cancer recurrence (on behalf of the EORTC Radiotherapy, Breast Cancer Groups) (2004) (4)
- Benefit of Post Mastectomy Radiation Therapy (PMRT) in Node-Positive, HER2-Positive Patients With Breast Cancer Receiving Anti-HER2 Treatments. (2020) (4)
- Combination of Modern Radiotherapy and New Targeted Treatments for Breast Cancer Management (2021) (4)
- [Shared responsibility for follow-up of breast cancer patients. Experience of the Institut Curie]. (2008) (4)
- Long-Term Prognostic Performance of Ki 67 Rate in Early Stage , pT 1pT 2 , pN 0 , Invasive Breast Carcinoma (2013) (4)
- Risk of Second Non Breast Malignancies (SNBM) in Relation to Brca1 And Brca2 Mutation Status Following Breast-Conserving Surgery and Radiotherapy (2006) (4)
- [High risk of cardiac dysfunction after treatment of secondary acute myeloid leukemia following chemotherapy and radiotherapy for breast cancer]. (2010) (3)
- Long-term follow-up results of intensity-modulated radiotherapy with helicoïdal tomotherapy for non-metastatic breast cancers: Single centre experience. (2022) (3)
- Radiation Boost for Ductal Carcinoma In Situ After Whole-Breast Radiation Therapy (WBRT) Improves Local Control: Analysis From 10 Pooled Academic Institutions (2016) (3)
- Abstract 87: Micropapillary breast carcinoma is characterized by deregulation of genes involved in cell division control (2012) (3)
- Concurrent Olaparib and Radiotherapy in Patients With Triple-Negative Breast Cancer: The Phase 1 Olaparib and Radiation Therapy for Triple-Negative Breast Cancer Trial. (2022) (3)
- Local and distant relapses in relation to age following breast-conserving surgery and irradiation in premenopausal patients with breast cancer (1998) (3)
- [Histological margin and residual disease assessment for breast carcinoma]. (2003) (3)
- [Management of inflammatory breast cancer after neo-adjuvant chemotherapy]. (2011) (3)
- The higher local recurrence rate after breast conserving therapy in young patients explained by larger tumor size and incomplete excision at first attempt (1998) (3)
- Abstract 4428: Pre-clinical studies of the therpaeutic effect of a PARP inhibitor combined with radiotherapy for breast cancer treatment. (2013) (3)
- No Evidence of Increased Skin Toxicity with Aromatase Inhibitors and Concurrent Hypofractionated Radiation Therapy in Menopausal Breast Cancer Patients (2010) (3)
- [Breast cancer follow-up by primary care physician: patient satisfaction in the Metropolitan Paris region]. (2012) (3)
- Patterns of locoregional failure in women with early-stage breast cancer treated by whole breast irradiation in the lateral isocentric decubitus position: Large-scale single-centre experience. (2019) (3)
- [Concurrent whole-brain radiotherapy with trastuzumab for treatment of brain metastases in breast cancer patients: questions and answers]. (2011) (2)
- The 1951-98 experience of the Paris Institut Curie Radiopathology Unit: a preliminary report (1999) (2)
- 142 Role of metachronous contralateral breast carcinoma in the outcome of breast cancer (1995) (2)
- [Radiotherapy of cancer of the breast. Technical problems and new approaches]. (2000) (2)
- [Intraductal cancer of the breast in women under age 35 years]. (1996) (2)
- Paget's disease of the nipple : Conservative management with radiation therapy (1986) (2)
- Cardiac radiation-induced sarcomas: A SEER population-based study and a literature review. (2020) (2)
- Helical tomotherapy for patients presented with implant breast reconstruction in case of adjuvant breast cancer radiotherapy: A single center experience (2019) (2)
- Institut Curie guidelines on breast target volume delineation for patients treated in lateral position. (2020) (2)
- [Hypofractionated breast radiotherapy in 13 fractions, perfect tolerance or delayed early reaction? Prospective study of Curie Institute]. (2009) (2)
- [Ductal carcinoma in situ diagnosis: 3 French national guidelines]. (2016) (2)
- Salvage treatment for recurrence in the breast following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast (1993) (2)
- Tolerance of concurrent CDK inhibitor and radiation therapy in metastatic breast cancer patients. (2020) (2)
- Outcome and prognostic factors of isolated breast recurrences in patients treated with breast-conserving surgery and radiotherapy for early breast cancer (2003) (2)
- PP-3-7 Long term time course of breast recurrence after breast-conservative treatment of small breast cancer (1996) (2)
- [Early stage breast cancer: is exclusive radiotherapy an option for early breast cancers with complete clinical response after neoadjuvant chemotherapy?]. (2011) (2)
- Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers (2007) (2)
- [Breast cancer without palpable tumor revealed by microcalcifications. Prognosis and treatment]. (1995) (2)
- A Therapeutic Challenge: Chemo-refractory Non-metastatic Inflammatory Breast Cancers (2022) (2)
- Salvage treatment for local recurrence after breast-conserving surgery followed by radiation as initial treatment for mammographically-detected ductal carcinoma in situ of the breast (2004) (2)
- The impact of a boost dose on the local recurrence rate in high risk patients after breast conserving therapy – results from the EORTC boost-no boost trial (2008) (2)
- [Prospective monocentric study of the toxicity and the efficacy of concurrent trastuzumab and radiotherapy]. (2013) (2)
- [Radiation-induced retinopathy]. (2002) (2)
- T-Cell Infiltrate After Monoclonal Anti-CD20 Antibody Therapy for B-Cell Lymphoma (2000) (2)
- ["Standards, Options and Recommendations 2001" for radiotherapy in patients with non-metastatic infiltrating breast cancer. Update. National Federation of Cancer Campaign Centers (FNCLCC)]. (2002) (2)
- O-62 External validation in ONCOPOOL of updated survival according to the Nottingham Prognostic Index (NPI) (2007) (2)
- [Concomitant association of radiotherapy and chemotherapy in inflammatory breast cancer. Initial results of phase II trial]. (1991) (2)
- Medullary Breast Carcinoma: Prognostic Implications of P53 Expression (2003) (2)
- Breast reconstruction after breast-cancer surgery. (2009) (2)
- Evaluation of Cardiac Conduction System Exposure with Breast Volumetric Modulated Arc Therapy and Intensity Modulated Proton Therapy. (2021) (1)
- Superoxide dismutase content of breast carcinoma: lack of relationship with radiosensitivity. (1986) (1)
- Evaluation of the early adverse effects of radiotherapy in breast cancer patients with COVID‐19: Prospective single institutional study (2021) (1)
- Abstract OT3-04-01: A phase I of olaparib with radiation therapy in patients with inflammatory, loco-regionally advanced or metastatic TNBC (triple negative breast cancer) or patient with operated TNBC with residual disease (2018) (1)
- Is Exclusive Radiotherapy an Option for Early Breast Cancers with Complete Clinical Response after Neoadjuvant Chemotherapy (2009) (1)
- Immobilization System and Set-up Variability of Patients with Large Pendulous Breasts Treated in the Lateral Decubitus Position (2011) (1)
- Corrigendum to “ONCOPOOL – A European database for 16,944 cases of breast cancer” [European Journal of Cancer 46 (2009) 56–71] (2010) (1)
- Pattern of relapse in low‐risk breast cancer patients followed within a community care network (2017) (1)
- Can We Consider Always an Esophageal Carcinoma as Radiation Associated Cancer After Irradiation for Breast Cancer? (2009) (1)
- Corrigendum to “Iridium-192 versus cobalt-60 boost in 3–7 cm breast cancer treated by irradiation alone: final result of a randomized trial” (1995) (1)
- 1BA The impact of pathological factors on long-term local control in the EORTC boost no-boost trial (2015) (1)
- Recent advances in breast cancer radiotherapy (2008) (1)
- [Value of granisetron in the prevention of digestive disorders in total body irradiation]. (1994) (1)
- 183 A DNA signature to identify high-risk small node-negative breast cancer patients (2010) (1)
- Radiotherapy in the Management of Non-Metastatic Inflammatory Breast Cancers: A Retrospective Observational Study (2021) (1)
- Concurrent use of palbociclib and radiation therapy: single-centre experience and review of the literature (2020) (1)
- Deep Inspiration Breath-Hold (DIBH) for Locoregional Breast Irradiation using Volumetric Modulated Arc Therapy (VMAT) and Intensity Modulated Proton Therapy (IMPT): A Dosimetric Comparison to Cardiac Substructure (2020) (1)
- [Long follow-up of breast cancer revealed by clustered microcalcifications without palpable mass]. (2004) (1)
- [Hypofractionated whole breast irradiation: Pro and cons]. (2011) (1)
- Does Semi-Quantitative Evaluation Improve the Prognostic Value of Histological Grade in Breast Carcinoma: Comparison of Scarff-Bloom-Richardson (SBR) and Elston-Ellis (EE) Grading Systems in a Series of 825 Cases with a Follow-Up of 10 Years (1996) (1)
- Craniospinal Irradiation (CSI) in Acute Lymphoblastic Leukemia: Comparison between Conformal Radiotherapy, Intensity-Modulated Radiotherapy, and Helical Tomotherapy (HT) (2012) (1)
- Optimal management of breast cancer with locoregional radiotherapy (2005) (1)
- 31 Brachytherapy boost parameters and local recurrence in breast cancer patients treated with conservative surgery and radiotherapy (2001) (1)
- Evaluation of a software for automatic delineation of the mammary gland and organs at risk in patients treated for breast cancer in lateral position. (2020) (1)
- Recurrent breast carcinoma after conservative treatment: MRI features and pathologic correlation (1994) (1)
- [Standards, options and recommendations for the management of patients with infiltrating non metastatic breast cancer (2nd edition, 2001)--summary version]. (2003) (1)
- 128 Locoregional recurrences in triple-negative, node-negative early stage breast cancer treated with breast-conserving treatment (2010) (1)
- Abstract P3-12-16: Hydrosorb® versus control (water based spray) in the management of radio-induced skin toxicity: Results of multicentre controlled randomized trial (2016) (1)
- Abstract P5-21-03: Concurrent loco-regional radiotherapy and trastuzumab in early-stage breast cancer: Long term results of prospective single-institution study (2012) (1)
- Can we treat with radiation breast cancer patients with covid-19 infection? Results from a prospective study (2022) (1)
- OC-0488: 17 year results of the randomized boost versus no boost EORTC 22881-10882 trial in early breast cancer (2014) (1)
- Abstract OT2-03-01: A phase one trial of olaparib with radiation therapy in patients with triple negative breast cancer: RADIOPARP (2020) (1)
- Whole Brain Radiotherapy with Concurrent Trastuzumab for Treatment of Brain Metastases in Breast Cancer Patients (2010) (1)
- How to Boost the Breast Tumor Bed? The Procedure Description Step by Step in 8 Phases (2007) (1)
- Unusual severe radiation-induced toxicity in a patient with discoid lupus erythematosus: A case report and critical review of the literature. (2021) (1)
- 2027 ORAL Predictors of increased risk of breast fibrosis at 10 years with higher radiation dose in the early breast cancer (EORTC “Boost versus no Boost” trial 22881–10882). (2007) (1)
- [Locoregional control and patterns of locoregional failure in women with breast cancer treated by highly conformal electron beam irradiation]. (2019) (1)
- Neoadjuvant Concurrent Radiotherapy and Chemotherapy in Early Breast Cancer Patients: Long-Term Results of a Prospective Phase II Trial (2021) (1)
- Cardiotoxicity of the Association Trastuzumab–Locoregional Breast Radiation Therapy: A Prospective Monocentric Study (2013) (1)
- [Adjuvant irradiation in breast cancer patients with ATM gene heterozygous mutations: special focus on clinical efficacy/toxicity]. (2009) (1)
- Scleroderma and radiotherapy as part of the treatment of breast carcinoma: Six cases and a short critical review of the literature (2007) (1)
- Predictors of local control following radiotherapy alone for breast cancer (1991) (1)
- Can Helical Tomotherapy be used as a Safe Treatment Alternative for Breast Cancer Patients (2012) (1)
- Patient population comparison between EORTC randomized trials 22922/10925 investigating internal mammary and medial supraclavicular (IM-MS) lymph node irradiation and 22881/10882 investigating the role of a boost in BCT (2005) (1)
- Postmastectomy Electron Beam Radiation Therapy (PMERT): Efficacy and Toxicity (2016) (1)
- Hyaluronic Acid vs. Simple Emollient for the Management of Radio-induced Early Skin Toxicity: Results of an Open-label, Phase III Trial (2010) (1)
- European Society for Therapeutic Radiology and Oncology (ESTRO) teaching course and workshop E6. Recent advances in breast cancer radiotherapy (2008) (1)
- Prospective and Comparative Evaluation of the Toxicity of Adjuvant Concurrent Chemo-radiotherapy after Neoadjuvant Chemotherapy for Breast Cancer (2011) (1)
- Helical Tomotherapy for Debulking Irradiation Prior to Stem Cells Transplantation in Malignant Lymphoma (2009) (1)
- Long-term results of a phase II trial of preoperative concurrent radiochemotherapy for breast cancers. (2010) (1)
- Dose received by the sentinel lymph node (SLN) clip – prospective comparative study of two radiotherapy (RT) techniques of breast irradiation (2008) (0)
- Radiotherapy in early breast cancer (2006) (0)
- Management of localized primary breast B-cell Non-Hodgkin's Lymphoma: Role of CNS prophylaxis. (2004) (0)
- [Cancers of the breast. Primary non-surgical treatments of so-called "operable" cancers of the breast]. (1995) (0)
- Assessment of Side Effects of Radiation Therapy in Patients With COVID-19 Treated for Early-Stage Breast Cancer (2021) (0)
- 103 Breast conserving surgery following primary irradiation in 3–7 cm breast cancer: Pathologic response and outcome (1997) (0)
- [Theory and practice of locoregional treatment in cancers of the breast]. (1992) (0)
- 463 Concurrent Radiotherapy and Trastuzumab in Early-stage Breast Cancer – A Prospective Single Institutional Experience (2012) (0)
- 99 Concurrent whole brain radiotherapy (WBRT) and trastuzumab (T) in breast cancer (BC) patients presenting with brain metastases (2010) (0)
- Long-Term Survival and Toxicity in Patients Treated With Radiotherapy for Neuroendocrine Breast Cancer: A Single-Center Experience. (2021) (0)
- Optimal Boost to Breast Tumor Bed: How to use the Clips and Initial Tumor Site? (2009) (0)
- 357 Tolerance of concurrent adjuvant trastuzumab and radiotherapy, involving in most cases the internal mammary chain, for breast cancer: results from a prospective study (2010) (0)
- OP-JNCI210114 1360..1368 (2021) (0)
- Genomic and transcriptomic differences between lobular and luminal ductal invasive carcinoma. (2009) (0)
- [Standards, Options and Recommendations (SOR) for endocrine therapy in patients with non metastatic breast cancer. FNCLCC]. (2000) (0)
- EP-2122 Outcome of exclusive RT for BC in older women according to age and comorbidity: A retrospective study (2019) (0)
- Randomized Phase 2 Study of Whole-Brain Radiation Therapy With or Without Concomitant Temozolomide for Brain Metastases From Breast Cancer (2014) (0)
- PO-0677: Rotational intensity Modulated Radiation Therapy in complex adjuvant breast and nodes irradiation (2015) (0)
- Second Malignancies After Breast Cancer Treatment and Their Relationship With Adjuvant Radiation Therapy: Long-term Results (2012) (0)
- Tumour Aromatase Expression, a Prognostic for Local Control in Young Breast Cancer Patients after Breast-Conserving Treatment? (2009) (0)
- Clinical outcomes of curative-intent multimodal management of chemorefractory nonmetastatic inflammatory breast cancer (2022) (0)
- Conservative treatment of breast cancer: When, how, and who? (1997) (0)
- Craniospinal Irradiation in Hematological Malignancies: Can the Helical Tomotherapy Become a Standard? (2011) (0)
- Bone marrow disseminated tumor cells, loco-regional and adjuvant treatment are prognostic factors for loco-regional relapses in early breast cancers. (2009) (0)
- Breast cancer in premenopausal women/should mastectomy be recommended? (1998) (0)
- PO-1088 Cardiac conduction system exposure during breast radiotherapy : evaluation of IMRT and protontherapy (2021) (0)
- E6. Radiotherapy in breast cancer (2002) (0)
- PD-0739 Neoadjuvant chemo-radiotherapy in early breast cancer patients:long-term results of a phase II trial (2022) (0)
- DCIS with close or focally involved margins following breast-conserving surgery (BCS): reexcision or radiotherapy with boost? (2008) (0)
- EP-1165: Short and long term safety of a post-mastectomy conformal electron beam radiotherapy (PMERT) (2017) (0)
- Radiotherapy in the Treatment of Solitary Plasmacytoma: New Technical Approaches and New Indications (2009) (0)
- PD02-08: Validation over Time of a Nomogram Predicting the Sentinel Node Positivity in Early Breast Carcinoma According to the Molecular Subtypes Classification. (2011) (0)
- Multidisciplinary management of patients with BRCA1 and BRCA2 mutations in institut Curie of paris (2006) (0)
- Anatomical, clinical and radiological delineation of target volumes in the radiotherapy planning of breast cancer: individual variability, questions and answers (2008) (0)
- Five‐year outcomes in patients treated with surgery and radiotherapy for primary neuroendocrine neoplasm of the breast (2021) (0)
- 769 poster POTENTIAL BENEFITS OF USING CARDIAC GATED IMAGES TO REDUCE THE DOSE TO THE LEFT ANTERIOR DESCENDING CORONARY DURING RADIOTHERAPY OF LEFT BREAST AND INTERNAL MAMMARY NODES (2011) (0)
- How to Boost the Breast Tumor Bed After Oncoplastic Surgical Procedure Using Surgical Clips and Image Registration (2012) (0)
- Patterns of loco-regional failure in women with early stage breast cancer treated by whole breast radiotherapy in lateral position: Large scale single center experience (2018) (0)
- Acquis et limites en sénologie / Assets and limits in breast diseases (2013) (0)
- Standards, Options and Recommendations for endocrine therapy in patientswith non metastatic breast cancer (2000) (0)
- Dosimetric evaluation of the benefit of deep inspiration breath hold (DIBH) for locoregional irradiation of right breast cancer with volumetric modulated arctherapy (VMAT) (2023) (0)
- EP-2388: Use of helical tomotherapy for local treatment in metastatic breast cancer: single center experience (2018) (0)
- One-Year Toxicity Report of the RADIOPARP Phase I Trial Evaluating Olaparib With Radiotherapy for Triple Negative Breast Cancer. (2021) (0)
- Safety and tolerability of olaparib combined with breast radiotherapy in patients with triple-negative breast cancer: Final results of the RADIOPARP phase 1 trial. (2022) (0)
- 775 Impact of BRCA2 Mutation in Primary Human Triple Negative Breast Cancer Xenografts on the Responses to Ionizing Radiation and in Vivo Tumor Growth after Treatment (2012) (0)
- Abstract P2-11-20: Tolerability and outcomes of radiation therapy for breast cancer in older women: A retrospective study in 817 patients (2018) (0)
- 114 Validation process of a gene-expression signature of local recurrences after breast-conserving treatments (2010) (0)
- [Treatment of intraductal breast cancers: results, role of radiotherapy]. (1990) (0)
- PO-0761 Hypofractionated whole breast irradiation safety after breast-conserving surgery for young patients (2019) (0)
- Pathological assessment after neoadjuvant therapy: not an easy task (2008) (0)
- PO-0655: Patterns of locorégional failure in women with breast cancer treated by Postmastectomy Radiotherapy (2017) (0)
- Évaluation nationale delatomothérapie hélicoïdale: description desindications, descontraintes dedose etdesseuils derepositionnement (2007) (0)
- Abstract P3-19-14: Development of simplified auto-segmentable functional cardiac atlas (2022) (0)
- The influence of the boost on the cosmetic outcome after breast conserving therapy (1998) (0)
- 1317 poster DOSE RATE ISSUES IN TOTAL BODY IRRADIATION DELIVERED WITH HELICAL TOMOTHERAPY (2011) (0)
- Risk of breast recurrence in relation to BRCA1/2 mutation status following breast-conserving surgery and radiotherapy (2004) (0)
- Multidisciplinary management and role of reirradiation in the treatment of a breast cancer patient with four locoregional recurrences. (2022) (0)
- Breast Non Hodgkin’s Lymphoma (NHL): A Large Monocentric Study of Initial Characteristics, Natural History, and Prognostic Factors. (2004) (0)
- Corrigendum to "A case-control study to identify molecular risk factors for local recurrence in young breast cancer patients" [Radiother Oncol 156 (2021) 127-135]. (2021) (0)
- Long-term Follow-up for Inflammatory Breast Cancer Patients: Institute Curie Experience (2010) (0)
- PO-1089 Long-term follow-up of a single-center neuroendocrine breast cancer cohort (2021) (0)
- [Breast conserving surgery in locoregional treatment of breast carcinoma after Hodgkin lymphoma]. (2012) (0)
- Pathological response to preoperative concurrent chemoradiotherapy for breast cancers considered too large for initial conserving surgery: results of a phase II study (2006) (0)
- Timing of radiotherapy and chemotherapy (2004) (0)
- 451 Locoregional treatment of inflammatory breast cancer after neoadjuvant chemotherapy (2010) (0)
- 379 Hyaluronic acid versus simple emollient for the management of radio-induced skin toxicity: results of an open-label, phase III trial (2010) (0)
- BRCA1Sequence Variations in160Individuals Referred toa Breast/ Ovarian Family CancerClinic (1997) (0)
- Value and indications of surgery in locally advanced breast cancers (1997) (0)
- Visualization of the Left Anterior Descending Coronary Artery on Computed Tomographic Images Used for the Planning of Breast Radiation Treatments (2012) (0)
- Abstract P2-11-08: Risk factors for fibrosis after whole breast radiation therapy in lateral position : A large scale single center experience (2018) (0)
- Primary C hemotherapy f or O perable B reast C ancer: Incidence a nd P rognostic S ignificance o f I psilateral B reast Tumor R ecurrence A fter B reast-Conservin g S urgery (2001) (0)
- Timing of combined chemoradiotherapy in the conservative treatment of locally advanced breast cancer (LABC) (1998) (0)
- 113 Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long term results and review of the literature (2010) (0)
- PO-0967: Toxicity of concurrent Palbociclib and Radiation therapy in metastatic breast cancer patients (2020) (0)
- Abstract P1-10-16: Cardiac conduction system exposure with modern radiotherapy techniques for breast cancer irradiation (2023) (0)
- OC-0159: Disseminated tumor cells as factor of benefit of regional lymph nodes irradiation in breast cancer (2018) (0)
- Abstract P1-10-17: Radiotherapy associated with concurrent bevacizumab in patients with non-metastatic breast cancer (2017) (0)
- 410 Lobular and luminal ductal invasive carcinoma of the breast – comparative molecular analysis (2010) (0)
- Axillary nodal irradiation in breast cancer: When and how? (1995) (0)
- Medullary breast carcinoma. Ten-year results in 108 patients treated in a single center (1998) (0)
- Long-term results and comparative analysis of normo fractionated (NF) and hypo fractionated (HF) adjuvant radiotherapy after breast conserving surgery in elderly (2008) (0)
- Long-term Results and Comparative Analysis of Adjuvant Radiotherapy after Breast Conserving Surgery in Elderly: Normo Fractionated (nf) and Hypo Fractionated (hf) (2008) (0)
- Abstract P4-12-05: A retrospective study of 27 patients with ER-positive, HER2 negative metastatic breast cancer treated with concomitant palbociclib and radiation therapy (2020) (0)
- DCIS Update: Escalation or De-escalation? Boost, Fractionation, and Omission of Radiation. (2023) (0)
- In Reply to Khosla et al. (2019) (0)
- Concurrent Use of Radiation Therapy and Targeted Molecules in the Breast Cancer Treatment (2017) (0)
- Does prior pregnancy influence breast cancer outcome in young women (1998) (0)
- Impact on the cosmetic outcome of concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conservative surgery: Differences between patient’s and doctor’s views (2006) (0)
- PO-1849: Evaluation of an automatic contouring software in breast cancer treated in lateral position (2020) (0)
- P04 Neuroblastoks stude IV chez des enfants is plus de un as: Resultats perlfuxires de l'etude lucky 5 100 patients non selectiones (1995) (0)
- E14. New techniques in radiotherapy of breast cancer (2014) (0)
- 761 poster IMPLANT BREAST RECONSTRUCTION FOLLOWED BY RADIOTHERAPY: CAN THE TOMOTHERAPY BECOME A STANDARD OF IRRADIATION? (2011) (0)
- RADIOPARP: A Phase I of Olaparib with Radiation Therapy (RT) in Patients with Inflammatory, Loco-regionally Advanced or Metastatic TNBC (Triple Negative Breast Cancer) or Patient with Operated TNBC with Residual Disease (2020) (0)
- [Normofractionated breast irradiation in breast cancer. Indications and benefits]. (2016) (0)
- Radiation therapy after breast-conserving surgery (2012) (0)
- The use of the BCT in the population included in the EORTC22922/10925 investigating elective lymph node irradiation comparing with 22881/10882 investigating the role of a boost in early breast cancer (2006) (0)
- CT-scan Based Localization of the Internal Mammary Chain (IMC) and Supra Clavicular Nodes (SCN) for Breast Cancer (BC) Radiation Therapy Planning (2005) (0)
- Basic principles of radiotherapy in ophtalmic oncology (2009) (0)
- 1586P Assessment of side effects of radiation therapy in patients with COVID-19 treated for early-stage breast cancer (2021) (0)
- 28 European transfer of breast cancer treatment technique (1996) (0)
- Inflammatory Breast Cancer: What Should Be the Locoregional Treatment after Primary Chemotherapy? (2009) (0)
- Radiation Exposure of Cardiac Conduction Nodes During Breast Proton Therapy (2023) (0)
- [Patient selection and early tolerance of whole breast irradiation according to the "Fast Forward" protocol: Preliminary results]. (2021) (0)
- 190 INVITED Partial breast irradiation–avalid option? (2007) (0)
- 2042 Does pregnancy influence breast cancer outcome in young women (1997) (0)
- Breast preservation following primary chemotherapy or primary radiotherapy in large breast cancer: A randomized trial (1993) (0)
- Radiation therapy after breast-conserving (2012) (0)
- Long-Term Results of Post Mastectomy Conformal Electron Therapy Technique (PMERT) with Bolus in Comparison with Post Mastectomy Conformal Photon Therapy (PMPhRT) without Bolus in Non-Metastatic Breast Cancer Patients (2018) (0)
- Simultaneous Integrated Boost in the Treatment of Breast Cancer: A Dosimetric Comparison of Helical Tomotherapy (HT) and Three-dimensional Conformal Radiotherapy (3D CRT) (2009) (0)
- Effects of superoxide dismutase (SOD) on late radiofibrosis following conservative treatment for breast cancer: A clinical and laboratory study (1993) (0)
- A multidisciplinary approach to boost the breast tumor bed in 8 phases (2008) (0)
- PO-1229 Radiotherapy-based management of non-metastatic Inflammatory breast cancers: a retrospective study (2022) (0)
- Abstract 3449: Impact ofBRCA2mutation in primary human triple negative breast cancer xenografts on the responses to ionizing radiation andin vivotumor growth after treatment (2012) (0)
- Author’s reply to Dr. Baltoyiannis and colleagues’ letter (2008) (0)
- EP-1254: Role of implantable venous devices in dose distribution: dosimetric and clinical considerations (2018) (0)
- [Treatment of borderline lesions and non-infiltrating carcinoma]. (1990) (0)
- Abstract P4-12-23: Institut Curie guidelines on breast target volume delineation for patients treated in lateral position (2020) (0)
- Patterns of Locoregional Failure in Women With Early Stage Breast Cancer Treated by Whole Breast Radiation Therapy in the Lateral Isocentric Decubitus Position: Large-Scale Single Center Experience (2017) (0)
- Dosimetric Findings and Acute Side Effects of Patients Treated in the Lateral Decubitus Position with Whole Breast Radiotherapy in Early-stage Breast Cancer (2011) (0)
- P4-09-01: Identification of Poor Prognosis T1T2N0 Luminal ERBB2-ve Breast Carcinomas. (2011) (0)
- Abstract P4-04-04: Polarity Abnormalities in Invasive Carcinomas of the Breast: Analysis of Invasive Micropapillary Carcinoma of the Breast (2010) (0)
- Irradiation policy for the internal mammary chain in the EORTC trial 22922/10925 (2004) (0)
- Abstract P1-10-01: Postmastectomy electron beams radiation therapy (PMERT) : long term results (2023) (0)
- Rotational Intensity Modulated Radiation Therapy in Complex Adjuvant Breast and Nodes Irradiation (2015) (0)
- Safety of hypofractionated whole breast irradiation after conservative surgery for patients aged less than 60 years: A multi-center comparative study (2019) (0)
- 247 Is exclusive radiotherapy an option for early breast cancers with complete clinical response after neoadjuvant chemotherapy (2010) (0)
- The higher local recurrence rate after breast conserving therapy in young patients explained by larger tumour size, incomplete excision at first attempt and smaller excision volume? (1998) (0)
- OC-0934 Outcomes of the EORTC 22922/10925 randomised trial according to the technique for nodal irradiation (2022) (0)
- Tamoxifene and hypofractionated radiotherapy for breast cancer in elderly women (1993) (0)
- Early Breast Cancer (Stage I and II): Tailored Radiotherapy for Very Young Women (2006) (0)
- [Biological, preclinical and clinical aspects of the association between radiation therapy and CDK4/6 inhibitors]. (2023) (0)
- Abstract P1-15-04: Luminal B Lobular Carcinomas In Situ Have a Higher Risk of Relapse Compared to the Other Molecular Types of Lobular Carcinomas In Situ: Results from a Pilot Retrospective Single Institution Study (2010) (0)
- 525 Follow-up after breast cancer by primary care physicians in the Ile-de-France region (2010) (0)
- Relapsed, Refractory, or Advanced Hodgkin Lymphoma: A Single-Center Experience. (2020) (0)
- SU‐FF‐T‐446: Deciphering Electron Dose Distributions in Ophthalmologic Radiation Therapy (2009) (0)
- EP-1180: Whole breast radiotherapy in Lateral Decubitus position : efficacy and toxicity (2017) (0)
- Delayed reaction after adjuvant whole breast radiotherapy at the dose of 42.9 Gy in 13 fractions over 5 weeks: the need for rapid post irradiation clinical assessment and who are the patients at risk? (2009) (0)
- Preliminary result of a mono-institutional, prospective study of skin and cardiac toxicities in breast cancer patients treated by concurrent adjuvant trastuzumab and radiotherapy involving in most cases the internal mammary chain. (2009) (0)
- Delayed Early Reaction after Adjuvant Whole Breast Radiotherapy at the Dose of 42.9 Gy in 13 Fractions Over 5 Weeks: The Need of Rapid Post Irradiation Clinics (2008) (0)
- Management of breast cancer in the elderly. (1995) (0)
- Management of localized primary breast B-cell Non-Hodgkin's Lymphoma: Role of CNS prophylaxis (2004) (0)
- O-9 ONCOPOOL – A European Database in 16,893 cases of breast cancer: comparison with SEER (2007) (0)
- Abstract P4-12-12: Outcomes of exclusive radiation therapy for breast cancer in older women according to age and comorbidity status: An observational retrospective study (2020) (0)
- P3-05-03: Transcriptomic Validation of Molecular Classification of Invasive Ductal Carcinoma Based on Immunohistochemical Markers and Grade. (2011) (0)
- Breast radiotherapy in women with pectus excavatum (funnel chest): is the lateral decubitus technique an answer? — a dosimetric study (2006) (0)
- Identification of three-genomic regions prognostic signature in small node-negative breast carcinomas. (2009) (0)
- CT-Imaging Protocol for Heart Delineation in The Radiation Therapy Preparation Workflow (2012) (0)
- Physical Rationale for Proton Therapy and Elements to Build a Clinical Center (2016) (0)
- In reply to Drs. Munshi and Jalali (2006) (0)
- [The role of radiotherapy in the treatment of breast cancers]. (1992) (0)
- 53 Local control related to Kerma rate in T2T3 breast cancers treated by external irradiation and brachytherapy (1996) (0)
- Abstract P3-19-24: Long-term follow-up results of intensity modulated radiotherapy in early-stage breast cancer patients (2022) (0)
- Abstract P4-12-32: Intensity modulated radiotherapy (IMRT) for breast and lymph node irradiation (2020) (0)
- EP-1273 PRELIMINARY RESULTS OF HELICAL TOMOTHERAPY FOR SOFT TISSUE SARCOMA OF THE THIGH (2012) (0)
- Impact on the cosmetic outcome of concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conservative surgery: Differences between patient's and doctor's views. (2006) (0)
- OC-0630 Olaparib combined with radiotherapy for TNBC: 1-year toxicity report of the RADIOPARP phase 1 trial (2021) (0)
- 307 oral RISK OF SECOND MALIGNANCIES (SM) AFTER BREAST CANCER (BC) TREATMENT AND THEIR RELATIONSHIP WITH THE ADJUVANT RADIOTHERAPY: LONG TERM RESULTS (2011) (0)
- Preliminary Results of the Use of Helical Tomotherapy (HT) in Advanced Nonmelanoma Skin Cancers (2012) (0)
- Tumour response to primary chemotherapy predicts breast conservation and survival (1993) (0)
- Radiotherapy in early breast cancer: who does not need it? (2006) (0)
- Concurrent Olaparib with Radiotherapy in Patients with Triple Negative Breast Cancer: Final Results of the RADIOPARP Phase 1 Trial (2022) (0)
- EP-1316: The use of Helical Tomotherapy in early stage breast cancer: indications, tolerance, efficacy (2018) (0)
- 13 No Axillary Surgery in Breast Cancer (2012) (0)
- The importance of patient's position in CT-scan based localization of the Internal Mammary Chain (IMC) and Supra Clavicular Nodes (SCN) for breast cancer (BC) radiation therapy planning (2006) (0)
- 186P Long-term follow-up results of intensity modulated radiotherapy in early-stage breast cancer patients (2021) (0)
This paper list is powered by the following services: